Psychiatry & Neurology, Sleep Medicine · Houston, TX
NPI
1619958873
Since 2005
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6560 Fannin St, Suite 802
Houston, TX, 77030
Phone (713) 441-3970
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
4,149 services
Medicare patients, 2024
822
Average age 73
Drug cost, 2024
$1.3M
1,668 prescriptions
Company payments, 2025
$22K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit Verma was code G0453 (continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)), 2,525 times for 195 patients. In total Amit Verma billed 4,149 services in 31 codes, and Medicare paid $205K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2,525 | 195 | $25.48 | $64K |
| 95720 Neurologic | Facility | 383 | 159 | $163.45 | $63K |
| 95861 Electrical Nerve Conductivity | Facility | 196 | 185 | $62.74 | $12K |
| 95939 Electrical Nerve Conductivity | Facility | 185 | 173 | $91.21 | $17K |
| 95938 Electrical Nerve Conductivity | Facility | 181 | 170 | $35.17 | $6,365 |
| 95816 Neurologic | Facility | 179 | 177 | $43.69 | $7,821 |
| 99214 Office E&M - Established | Office | 157 | 101 | $77.10 | $12K |
| 95819 Neurologic | Facility | 139 | 138 | $42.96 | $5,971 |
| 95718 Neurologic | Facility | 101 | 92 | $103.72 | $10K |
| 95812 Neurologic | Facility | 25 | 25 | $34.25 | $856 |
| 95822 Neurologic | Facility | 14 | 14 | $44.45 | $622 |
| 99442 Telephone Services | Office | 13 | 13 | $36.87 | $479 |
By year: 2022 $261K for 4,474 services; 2023 $210K for 4,033 services; 2024 $205K for 4,149 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit Verma prescribed most often to Medicare patients was Levetiracetam, with 319 prescriptions and refills. In total Amit Verma wrote 1,668 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 319 | 754 | 81 | $17K |
| Levetiracetam Er Levetiracetam | 127 | 337 | 37 | $7,707 |
| Xcopri Cenobamate | 119 | 159 | 20 | $220K |
| Lamotrigine Generic | 108 | 259 | 29 | $2,810 |
| Clobazam Generic | 103 | 158 | 21 | $29K |
| Briviact Brivaracetam | 88 | 111 | 15 | $195K |
| Fycompa Perampanel | 86 | 98 | 12 | $120K |
| Zonisamide Generic | 69 | 157 | 14 | $2,894 |
| Lacosamide Generic | 68 | 174 | 25 | $22K |
| Topiramate Generic | 50 | 92 | 13 | $818 |
| Vimpat Lacosamide | 45 | 64 | Under 11 | $60K |
| Keppra Levetiracetam | 39 | 79 | Under 11 | $145K |
| Oxcarbazepine Generic | 38 | 114 | 11 | $3,535 |
| Clonazepam Generic | 35 | 53 | Under 11 | $405 |
| Carbamazepine Generic | 31 | 67 | Under 11 | $1,734 |
Brand drugs: 521 claims; generic drugs: 1,124 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit Verma $22K ($22K in general payments such as food, travel and fees) from 10 companies. The largest payer was SK Life Science, Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 37 | $13K |
| Neurelis, Inc. | 11 | $8,343 |
| UCB, Inc. UCB.BR | 12 | $437 |
| Jazz Pharmaceuticals Inc. JAZZ | 12 | $228 |
| Monteris Medical Corporation | 1 | $132 |
| Aucta Pharmaceuticals, Inc. | 7 | $87.31 |
| Otter Pharmaceuticals, LLC | 2 | $72.25 |
| Catalyst Pharmaceuticals, Inc. CPRX | 2 | $39.46 |
| SpringWorks Therapeutics, Inc. | 1 | $26.62 |
| Genentech USA, Inc. ROG.SW | 1 | $15.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.